Merck (MKGAY.PK), a leading science and technology company, reported that its net income, or profit after tax attributable to shareholders, declined in 2015 by 3.7% to 1.1 billion euros from 1.2 billion euros, prior year. The company said this was attributable to one-time expenses in connection with the Sigma-Aldrich takeover and integration as well as higher interest expenses to finance the acquisition. Operating result or EBIT rose by 4.6% to 1.8 billion euros. EBITDA pre exceptionals, increased by 7.1% to 3.6 billion euros. Earnings per share pre exceptionals was 4.87 euros compared to 4.60 euros.
from RTT - Earnings http://ift.tt/1ToigR4
via IFTTT
No comments:
Post a Comment